Activated Mast Cells Combined with NRF2 Predict Prognosis for Esophageal Cancer.
Journal of oncology(2023)
摘要
We presume that NRF2 combined with AC-MCs could be a marker to predict prognosis and could influence immunotherapy through regulating PD-L1 in the EC.
更多查看译文
关键词
esophageal cancer,nrf2 predict prognosis,mast cells
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要